Zoe’s approach to scoring companies at different maturity stages. A pre-seed company is judged differently than a PE portfolio company — at pre-seed, C-Suite Health and Vision & Strategy dominate; at growth stage, Financial Vitality and Delivery & Execution carry more weight. Stage-weighted scoring prevents apples-to-oranges comparison across a mixed portfolio.
You have a deal on the table. Run a Zoe diagnostic before you sign.
Join 200+ firms on the waitlist
